Last reviewed · How we verify
IRON SUCROSE — Competitive Intelligence Brief
marketed
Parenteral Iron Replacement [EPC]
Small molecule
Live · refreshed every 30 min
Target snapshot
IRON SUCROSE (IRON SUCROSE).
Comparator set (3 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| IRON SUCROSE TARGET | IRON SUCROSE | marketed | Parenteral Iron Replacement [EPC] | 2000-01-01 | ||
| Feraheme | FERUMOXYTOL | Covis | marketed | Parenteral Iron Replacement [EPC] | 2009-01-01 | |
| Sodium Ferric Gluconate Complex in Sucrose. | Sodium Ferric Gluconate Complex in Sucrose. | Watson Pharmaceuticals | marketed | Parenteral Iron Replacement [EPC] | ||
| SUCROSE | SUCROSE | marketed | Parenteral Iron Replacement [EPC] |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Parenteral Iron Replacement [EPC] class)
- · 2 drugs in this class
- Covis · 1 drug in this class
- Watson Pharmaceuticals · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- IRON SUCROSE CI watch — RSS
- IRON SUCROSE CI watch — Atom
- IRON SUCROSE CI watch — JSON
- IRON SUCROSE alone — RSS
- Whole Parenteral Iron Replacement [EPC] class — RSS
Cite this brief
Drug Landscape (2026). IRON SUCROSE — Competitive Intelligence Brief. https://druglandscape.com/ci/iron-sucrose. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab